Comments from the Director
During preparation of the last 2014 Issues of “The Bridge” I found that in several of our recent Issues there has been a lot of emphasis on instrumentation. I have commented several times previously that I foresee an increase in the use of this kind of instrumentation as we move into 2015 and beyond due to the changing regulations and registrations of the many European (German) remedies that we have come to rely on. How does the practitioner maintain a natural or biological medicine approach with their patients when important remedies simply disappear off our domestic market? Many – or even most – naturopathic and homeopathic practitioners rely on the sale of remedies (or supplements) for the majority of their clinic income. By turning to instrumentation and the use of electronically stored remedy frequencies, you can once again access and utilize these remedies but can no longer “prescribe” or “sell” them. Thus a whole new process and method of delivery to the patient is needed along with a changing dynamic in the income resources for the practice.
Over the past year you have seen the changes in how OIRF presents our information and in how we ask for your support both financially and politically. As I prepared the following basic information on the new BioResonance device models, I thought it was appropriate and important to once again reiterate the Institute’s Instrumentation Policies:
Following are four short and much abbreviated descriptions of the various models of true BioResonance devices available to us today. In telling you about these devices I am in essence recommending products from two competitive companies. Med-Tronik is the original BioResonance firm known for development of MORA-Therapy devices with a history dating back to the late 1970’s. BioKat is a newer firm founded in 2012 which separated from Med-Tronik, but which is also able to offer us true BioResonance fully to the standards and development of Dr. Franz Morell and the engineer Erich Rasche. All devices with the exception of the MORA Beauty have the ability to do Remedy Information Transfer!
As a non-profit corporation, OIRF must always maintain a certain amount of neutrality with our instrumentation recommendations. Although the two companies are competitive in nature due to their shared development history, at this time I do not see their products as competitive. Just like we can see competition between various car companies, each make and model gives us transportation from A to B but also gives us choices for which accessories, qualities, costs, capabilities, etc. will appeal to our personality, budget and application. And so instead of “competition” I instead perceive this as the availability of several high quality but distinctive models each offering us different capabilities.
I thank you for your interest . . .
s/ Carolyn
Carolyn L. Winsor-Sturm
Managing Director
An Infomrational Commentary for Supporters
From THE BRIDGE Newsletter of OIRF
Published November 2014
© Copyright 2014, Occidental Institute/Winsor, BC Canada
Comments from the Director
During preparation of the last 2014 Issues of “The Bridge” I found that in several of our recent Issues there has been a lot of emphasis on instrumentation. I have commented several times previously that I foresee an increase in the use of this kind of instrumentation as we move into 2015 and beyond due to the changing regulations and registrations of the many European (German) remedies that we have come to rely on. How does the practitioner maintain a natural or biological medicine approach with their patients when important remedies simply disappear off our domestic market? Many – or even most – naturopathic and homeopathic practitioners rely on the sale of remedies (or supplements) for the majority of their clinic income. By turning to instrumentation and the use of electronically stored remedy frequencies, you can once again access and utilize these remedies but can no longer “prescribe” or “sell” them. Thus a whole new process and method of delivery to the patient is needed along with a changing dynamic in the income resources for the practice.
Over the past year you have seen the changes in how OIRF presents our information and in how we ask for your support both financially and politically. As I prepared the following basic information on the new BioResonance device models, I thought it was appropriate and important to once again reiterate the Institute’s Instrumentation Policies:
Following are four short and much abbreviated descriptions of the various models of true BioResonance devices available to us today. In telling you about these devices I am in essence recommending products from two competitive companies. Med-Tronik is the original BioResonance firm known for development of MORA-Therapy devices with a history dating back to the late 1970’s. BioKat is a newer firm founded in 2012 which separated from Med-Tronik, but which is also able to offer us true BioResonance fully to the standards and development of Dr. Franz Morell and the engineer Erich Rasche. All devices with the exception of the MORA Beauty have the ability to do Remedy Information Transfer!
As a non-profit corporation, OIRF must always maintain a certain amount of neutrality with our instrumentation recommendations. Although the two companies are competitive in nature due to their shared development history, at this time I do not see their products as competitive. Just like we can see competition between various car companies, each make and model gives us transportation from A to B but also gives us choices for which accessories, qualities, costs, capabilities, etc. will appeal to our personality, budget and application. And so instead of “competition” I instead perceive this as the availability of several high quality but distinctive models each offering us different capabilities.
I thank you for your interest . . .
s/ Carolyn
Carolyn L. Winsor-Sturm
Managing Director
From THE BRIDGE Newsletter of OIRF
Published November 2014
© Copyright 2014, Occidental Institute/Winsor, BC Canada
About the author
Carolyn L. Winsor
Carolyn’s decades-long involvement with the work of OIRF has given her the tools and skills to offer you unique and valuable insights into the ongoing developments in this always expanding field. Her Biological Medicine background includes:
Credentials
Featured News
Background of Resonance Therapy According to Dr. Helmut W. Schimmel (2)
Part 2: Pathogenetic Resonance Chains As early as the 1970’s Dr. Schimmel noticed that many chronic diseases had common pathogenetic patterns. Normally then two [...]
The Healing Strength of the Inner Pictures
The First Investigations into the Effect of “Emotional Process Monitoring” (epb) on the Human Organism and on the Symptom Change in Migraine Patients [...]
Alkaline Terrain and Cancer:
How Alkalinizing Agents Can Reduce the Risk of Cancer Over the last few years there has been much scholarly discussion about the efficacy of [...]
Post-Vaccine Syndrome
Basic Countermeasures, Part II In the last issue of Raum&Zeit Florian Schilling explained why the C-vaccines so dramatically weaken the [...]
Sign-up to receive updates sent straight to your inbox